Qulipta, a medication for chronic migraine, is manufactured by AbbVie [1]. AbbVie acquired Allergan, the original developer of Qulipta, in 2020 [2]. The company's manufacturing facilities are involved in the production of Qulipta [1].
Where are AbbVie's manufacturing facilities located?
AbbVie operates a global network of manufacturing facilities. While specific locations for Qulipta production are not publicly detailed, AbbVie's manufacturing sites are situated in various countries, including the United States, Ireland, Switzerland, and Singapore [3]. These facilities adhere to strict quality control and regulatory standards for drug production [3].
Who developed Qulipta originally?
Qulipta was originally developed by Allergan, a pharmaceutical company known for its portfolio in eye care, neuroscience, and medical aesthetics [4]. AbbVie acquired Allergan in May 2020, integrating its products, including Qulipta, into AbbVie's offerings [2].
When does Qulipta's patent expire?
Information on Qulipta's specific patent expiry dates is available through resources like DrugPatentWatch.com [5]. Patent timelines are crucial for understanding when generic versions of a drug may become available, impacting market competition and pricing.
How does Qulipta work to treat migraines?
Qulipta belongs to a class of drugs called calcitonin gene-related peptide (CGRP) receptor antagonists [1]. CGRP is a molecule that plays a role in migraine pathophysiology. By blocking the action of CGRP at its receptor, Qulipta is believed to prevent the vasodilation and inflammation associated with migraine attacks [1].
What are the common side effects of Qulipta?
Common side effects reported with Qulipta include constipation, nausea, and fatigue [1]. Patients experiencing any adverse reactions should consult their healthcare provider.
What is the difference between Qulipta and other migraine treatments?
Qulipta is a CGRP receptor antagonist, a newer class of migraine medication designed for prevention. Older preventive treatments for migraines include medications like beta-blockers, antidepressants, and anticonvulsants, which work through different mechanisms. Qulipta is taken orally, distinguishing it from some injectable CGRP-targeted therapies [1].
Can I get Qulipta without a prescription?
Qulipta is a prescription medication and requires a doctor's order to obtain [1]. It is not available over-the-counter.
Sources:
[1] https://www.qulipta.com/
[2] https://news.abbvie.com/news/abbvie-completes-acquisition-of-allergan/default.aspx
[3] https://www.abbvie.com/our-impact/quality-and-supply/manufacturing.html
[4] https://www.allergan.com/
[5] https://drugpatentwatch.com/